« Back
Home /
Pemetrexed disodium

Pemetrexed disodium

Item no.	TMO-T0189L-200mg
Manufacturer	TargetMol
CASRN	150399-23-8
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 20 mg 25 mg 2 mg 500 mg 50 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Lung Cancer
Type	Molecules
Specific against	other
Purity	0,98
Smiles	[Na+].[Na+].Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)c2c(=O)[nH]1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	LY231514 disodium
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|DNA/RNA Synthesis\|\|\|Autophagy\|\|\|Antifolate\|\|\|DHFR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	471.37
Description	Pemetrexed disodium (LY-231514) is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed disodium therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.
Pathways	Metabolism\|\|\|DNA Damage/DNA Repair\|\|\|Autophagy\|\|\|Cell Cycle/Checkpoint\|\|\|Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0189L-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question